Literature DB >> 11164114

Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population.

S W Wen1, K Demissie, S Liu.   

Abstract

PURPOSE: There has been little attention paid to asthma complicating pregnancy. This study is among the few studies that investigated this issue in a large Canadian population (more than two millions of Canadian pregnant women).
METHODS: We carried out a historical cohort study using hospital discharge data collected by the Canadian Institute for Health Information for fiscal years 1989/90 to 1995/96.
RESULTS: A total 2,017,553 obstetric deliveries were included in the analysis. Overall prevalence of asthma among these Canadian women were 0.43%, yielding a total of 8672 cases of asthmatic mothers. Maternal asthma was associated with all of the adverse pregnancy outcomes examined (including fetal death, preterm labour, hypertensive disorders of pregnancy, gestational diabetes, antepartum hemorrhage, infection of the amniotic cavity, premature rupture of membrane, cesarean delivery, as well as postpartum hemorrhage), and adjustment for important confounding factors by multiple logistic regression analysis did not change the overall results. These associations were consistently observed in teenage and adult mothers, although the associations in teenage mothers tended to be stronger than in adult mothers.
CONCLUSIONS: This study confirms that pregnant women with asthma are at substantially increased risk for many adverse pregnancy outcomes. For this reason, pregnant women with asthma are a particularly high-risk group to which extra attention, including increased efforts at education, monitoring, and optimal asthma management, may be appropriate.

Entities:  

Mesh:

Year:  2001        PMID: 11164114     DOI: 10.1016/s1047-2797(00)00077-6

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  15 in total

1.  Does maternal asthma contribute to racial/ethnic disparities in obstetrical and neonatal complications?

Authors:  Katrina F Flores; Candace A Robledo; Beom Seuk Hwang; Kira Leishear; Katherine Laughon Grantz; Pauline Mendola
Journal:  Ann Epidemiol       Date:  2015-01-30       Impact factor: 3.797

2.  Impact of maternal asthma on perinatal outcomes: a two-stage sampling cohort study.

Authors:  Faranak Firoozi; Catherine Lemière; Marie-France Beauchesne; Sylvie Perreault; Amélie Forget; Lucie Blais
Journal:  Eur J Epidemiol       Date:  2012-03       Impact factor: 8.082

3.  Asthma in pregnancy and its pharmacologic treatment.

Authors:  Carol Louik; Michael Schatz; Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Ann Allergy Asthma Immunol       Date:  2010-08       Impact factor: 6.347

4.  The Incidence of Allergic Disorders in First Degree Relatives of Neonates with Transient Tachypnea of Neonate.

Authors:  Mojgan Safari; Behnaz Basiri; Mehdi Ghaeeni
Journal:  J Clin Diagn Res       Date:  2015-08-01

5.  Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study.

Authors:  Marie-Josée Martel; Evelyne Rey; Marie-France Beauchesne; Sylvie Perreault; Geneviève Lefebvre; Amélie Forget; Lucie Blais
Journal:  BMJ       Date:  2005-01-19

6.  Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications.

Authors:  Bengt Källén; Petra Otterblad Olausson
Journal:  Eur J Clin Pharmacol       Date:  2007-01-30       Impact factor: 2.953

7.  Use of anti-asthmatic drugs during pregnancy. 2. Infant characteristics excluding congenital malformations.

Authors:  Bengt Källén; Petra Otterblad Olausson
Journal:  Eur J Clin Pharmacol       Date:  2007-01-30       Impact factor: 2.953

8.  Asthma in children in relation to pre-term birth and fetal growth restriction.

Authors:  Gibby Koshy; Kafya A S Akrouf; Yvonne Kelly; Ali Delpisheh; Bernard J Brabin
Journal:  Matern Child Health J       Date:  2013-08

Review 9.  Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.

Authors:  Camilla Christensson; Anders Thorén; Bengt Lindberg
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Antenatal steroid therapy for fetal lung maturation and the subsequent risk of childhood asthma: a longitudinal analysis.

Authors:  Jason D Pole; Cameron A Mustard; Teresa To; Joseph Beyene; Alexander C Allen
Journal:  J Pregnancy       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.